INSMED INC's ticker is and the CUSIP is 457669AA7. A total of 44 filers reported holding INSMED INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $8,517,000 | -1.0% | 8,193,000 | -0.1% | 0.02% | -4.8% |
| Q2 2021 | $8,603,000 | -82.6% | 8,198,000 | -81.4% | 0.02% | -83.3% |
| Q1 2021 | $49,364,000 | +7.8% | 44,150,000 | +8.7% | 0.13% | +4.1% |
| Q4 2020 | $45,793,000 | -18.4% | 40,625,000 | -21.1% | 0.12% | -32.4% |
| Q3 2020 | $56,108,000 | +89.5% | 51,465,000 | +69.8% | 0.18% | +72.1% |
| Q2 2020 | $29,604,000 | +66.3% | 30,305,000 | +42.6% | 0.10% | +31.6% |
| Q1 2020 | $17,806,000 | -43.9% | 21,251,000 | -35.4% | 0.08% | -25.5% |
| Q4 2019 | $31,760,000 | +598.3% | 32,884,000 | +604.9% | 0.11% | +606.7% |
| Q2 2019 | $4,548,000 | -70.5% | 4,665,000 | -69.3% | 0.02% | -70.6% |
| Q1 2019 | $15,406,000 | +306.5% | 15,199,000 | +187.2% | 0.05% | +264.3% |
| Q4 2018 | $3,790,000 | -60.4% | 5,293,000 | -53.3% | 0.01% | -48.1% |
| Q3 2018 | $9,575,000 | -30.9% | 11,324,000 | -24.7% | 0.03% | -34.1% |
| Q2 2018 | $13,858,000 | +60.7% | 15,034,000 | +54.1% | 0.04% | +57.7% |
| Q1 2018 | $8,625,000 | – | 9,754,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Worth Venture Partners, LLC | 2,974,000 | $2,536,000 | 1.90% |
| Mohican Financial Management, LLC | 500,000 | $422,000 | 1.47% |
| LINDEN ADVISORS LP | 51,146,000 | $43,311,000 | 1.32% |
| ZAZOVE ASSOCIATES LLC | 15,101,000 | $12,810,000 | 1.11% |
| DLD Asset Management, LP | 24,500,000 | $20,911,000 | 1.03% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 31,749,000 | $26,863,000 | 0.55% |
| Cheyne Capital Management (UK) LLP | 1,000,000 | $853,000 | 0.51% |
| SSI INVESTMENT MANAGEMENT LLC | 6,000,000 | $5,050,000 | 0.39% |
| Jabre Capital Partners S.A. | 1,100,000 | $943,000 | 0.31% |
| Orbimed Advisors | 26,500,000 | $22,611,000 | 0.27% |